Metabolic benefits of oral polymer-based duodenal exclusion therapyGlyscend Therapeutics has presented preclinical study results at EASD 2021 evaluating the metabolic effects of once-daily oral therapy in...
Factors influencing pharmacokinetic changes following restrictive and metabolic bariatric surgery2 days ago
Mazdutide superior compared with dulaglutide for glycaemic control, weight loss, blood lipid and pressure2 days ago